An Efficacy and Safety Study of Oral Osmotic Therapeutic System (OROS) Hydromorphone Hydrochloride (HCl) in Participants With Cancer Related Pain
Clinical trial NCT01205126 · COMPLETED
Trial details
- NCT number
- NCT01205126
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-02-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.